CompletedPhase 3NCT00266578

A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders

Studying NON RARE IN EUROPE: Eosinophilic esophagitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Marc Rothenberg
Principal Investigator
Marc E. Rothenberg, M.D., Ph.D.
Children's Hospital Medical Center, Cincinnati
Intervention
Fluticasone Propionate(drug)
Enrollment
30 enrolled
Eligibility
3-30 years · All sexes
Timeline
20022012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00266578 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Eosinophilic esophagitis

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Eosinophilic esophagitis

← Back to all trials